Table 2.

Summary of study characteristics and costs per DALY averted for interventions targeting pregnant women

References	Publication year	Country/region	Malaria intervention	Main data sources	Life tables source	Cost-effectiveness threshold used	Cost-effectiveness ratio (cost per DALY averted)	DALYs averted per $ 1 million spent on intervention
[1]	1999	Sub-Saharan Africa	ITNs, residual spraying, chemoprophylaxis and improved malaria treatment	Published and unpublished sources Programmes	GBD study	US$ 30–US$ 150	$4–$10 for treatment of existing nets	142,857
							$19–$85 for residual spraying	19,231
							$3–$12 chemoprophylaxis for children	133,333
							$4–$29 for pregnant women treatment	58,997
							$1–$8 for case management	222,222
[2]	2001	Non-specific	Sulfadoxine–pyrimethamine	Published and unpublished data	Kenyan life table	Not stated	$10–14	83,333
[3]	2009	DRC	Insecticide treated nets (ITNs) distribution	Clinic records, program records and peer-reviewed literature	WHO life table	1–3 times GDP per capita	$17.22	58,072
[4]	2010	Mozambique	Intermittent preventive treatment	Demographic surveillance system	Mozambique life table	US$ 36–US$ 129	$41.46 (maternal malaria)	24,120
[5]	2015	Model	Intermittent preventive treatment	Published data	GBD (2010 and 2004)	1–3 times GDP per capita	$7.28	137,363
[6]	2015	Multi-country	Intermittent preventive treatment	Clinical trials Published data	Country-specific	US$ 240	$136.30	7337